These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37655782)

  • 1. Dihydroergotamine extravasation: prolonged arterial vasospasm requiring medical and surgical treatment.
    Martin K; Fuller J; Shaker KA; Sharma K
    Clin Toxicol (Phila); 2023 Aug; 61(8):621-622. PubMed ID: 37655782
    [No Abstract]   [Full Text] [Related]  

  • 2. Refractory vasospasm occurring in a trauma patient receiving dihydroergotamine and heparin.
    Shackford SR; Davis JW
    Crit Care Med; 1988 Sep; 16(9):909-10. PubMed ID: 3402234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of a patient with unintended intravenous dihydroergotamine infusion extravasation causing brachial artery vasospasm.
    Sheng J; Ebeling C
    Proc (Bayl Univ Med Cent); 2023; 36(3):400-402. PubMed ID: 37091758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arterial vasospasm as a complication of the prevention of thromboembolism with heparin-dihydroergotamine and its treatment].
    Schott G; Riedel K
    Zentralbl Chir; 1986; 111(21):1354-7. PubMed ID: 3101315
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vasospasm during thromboembolism prevention using heparin-dihydroergotamine].
    Rumpf KD; van den Berg E; Fröhlich H
    Dtsch Med Wochenschr; 1982 Sep; 107(36):1370-3. PubMed ID: 7117148
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible vasospasm in association with the use of heparin and dihydroergotamine.
    Bachner EJ; Konsens RM; Priem L; King T; Froimson AI
    Clin Orthop Relat Res; 1992 Oct; (283):261-4. PubMed ID: 1395256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute ischemia due to vasospasm following prevention of thrombosis with dihydroergotamine/heparin].
    Meybier H; Krämer KL; Maeder N; Kretzschmar U; Allenberg JR
    Rontgenpraxis; 1987 Aug; 40(8):287-94. PubMed ID: 3660102
    [No Abstract]   [Full Text] [Related]  

  • 8. Ergotism with acute limb ischemia, provoked by HIV protease inhibitors interaction with ergotamine, rescued by multisite transluminal balloon angioplasty.
    Mohamedi N; Mirault T; Durivage A; Di Primio M; Khider L; Detriche G; El Batti S; Sapoval M; Messas E; Goudot G
    J Med Vasc; 2021 Feb; 46(1):13-21. PubMed ID: 33546816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe arterial spasm in a patient after treatment with dihydroergotamine heparin].
    Magnusson I; Kulling KG; Lund F; Magaard F; Stånge K; Törngren S
    Lakartidningen; 1986 Mar; 83(11):967-9. PubMed ID: 3959671
    [No Abstract]   [Full Text] [Related]  

  • 10. Dihydroergotamine-induced vasospastic angina in a patient taking a calcium channel blocker.
    Schenkat DH; Schulz LT; Johnson BD
    Ann Pharmacother; 2011 Jul; 45(7-8):e41. PubMed ID: 21693700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gangrene and renal failure caused by dihydroergotamine used to treat raised intracranial pressure following head trauma.
    Gupta VL; Mjørndal TO
    Acta Anaesthesiol Scand; 1996 Mar; 40(3):389-91. PubMed ID: 8721476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergotism as a consequence of thromboembolic prophylaxis.
    Ashenburg RJ; Phillips DA
    Radiology; 1989 Feb; 170(2):375-6. PubMed ID: 2911661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of portal thrombosis arisen after treatment with dihydroergotamine.
    Iaquinto G; Ambrosone L; Rotiroti D; Cianciulli GM; Rambaldi M
    Ital J Gastroenterol; 1991 May; 23(4):219-21. PubMed ID: 1751820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory caffeine and ergot-induced cervico-cerebral vasospasm and stroke treated with combined medical and endovascular approach.
    Miller M; Kumar AB; Callison CR
    Neuroradiology; 2012 Jan; 54(1):77-9. PubMed ID: 21468675
    [No Abstract]   [Full Text] [Related]  

  • 15. [Risk of arterial vasospasms caused by the administration of dihydroergotamine (Dihytamin)--a case report].
    Lange T
    Anaesthesiol Reanim; 1987; 12(3):177-81. PubMed ID: 3620072
    [No Abstract]   [Full Text] [Related]  

  • 16. Brachial Artery Vasospasm From Sequential Use of Intravenous Promethazine and Dihydroergotamine for Treatment of Status Migrainosus: A Case Report.
    Johns C; Ardakani R; Das RR; Friedman DI; Frolov A
    Neurohospitalist; 2023 Apr; 13(2):196-199. PubMed ID: 37064942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral upper extremity ischemia after administration of dihydroergotamine-heparin for prophylaxis of deep venous thrombosis.
    Seifert KB; Blackshear WM; Cruse CW; Schwartz JA; Suslavitch F
    J Vasc Surg; 1988 Oct; 8(4):410-4. PubMed ID: 3139897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk of treatment with dihydroergotamine in pregnancy].
    Goeschen K; Saling E
    Geburtshilfe Frauenheilkd; 1984 Jun; 44(6):403-5. PubMed ID: 6564980
    [No Abstract]   [Full Text] [Related]  

  • 19. St. Anthony's fire: successful reversal of ergotamine-induced peripheral vasospasm by hydrostatic dilatation.
    Baader W; Herman C; Johansen K
    Ann Vasc Surg; 1990 Nov; 4(6):597-9. PubMed ID: 2261328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower-limb vasospasm and renal failure during postoperative thromboprophylaxis. Case report.
    Mattsson E; Ohlin A; Balkfors B; Fredin HO; Nilsson P; Bergqvist D
    Eur J Surg; 1991 Apr; 157(4):289-92. PubMed ID: 1677286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.